What's new in therapeutic drug monitoring of antimicrobials?
- PMID: 37133741
- PMCID: PMC10353963
- DOI: 10.1007/s00134-023-07060-5
What's new in therapeutic drug monitoring of antimicrobials?
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, Study D DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58:1072–1083. doi: 10.1093/cid/ciu027. - DOI - PubMed
-
- Ewoldt TMJ, Abdulla A, Rietdijk WJR, Muller AE, de Winter BCM, Hunfeld NGM, Purmer IM, van Vliet P, Wils EJ, Haringman J, Draisma A, Rijpstra TA, Karakus A, Gommers D, Endeman H, Koch BCP. Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial. Intensive Care Med. 2022;48:1760–1771. doi: 10.1007/s00134-022-06921-9. - DOI - PMC - PubMed
-
- Lanckohr C, Boeing C, De Waele JJ, de Lange DW, Schouten J, Prins M, Nijsten M, Povoa P, Morris AC, Bracht H. Antimicrobial stewardship, therapeutic drug monitoring and infection management in the ICU: results from the international A- TEAMICU survey. Ann Intensive Care. 2021;11:131. doi: 10.1186/s13613-021-00917-2. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
